Plasmonic Nanophotothermal Therapy of Atherosclerosis (NANOM-FIM)
Plasmonic Photothermal Therapy of Flow-Limiting Atherosclerotic Lesions With Silica-Gold Nanoparticles: a First-in-Man Study
Sponsor: De Haar Research Task Force
Listed as NCT01270139, this NA trial focuses on Atherosclerosis and Heart Failure and remains completed. Sponsored by De Haar Research Task Force, it has been updated 13 times since 2007, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2021 — Jul 2024 [monthly]
Completed NA
-
Apr 2021 — Dec 2021 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Completed NA
-
Jul 2019 — Jan 2021 [monthly]
Completed NA
-
Mar 2019 — Jul 2019 [monthly]
Completed NA
-
Jan 2019 — Mar 2019 [monthly]
Completed NA
-
Jun 2018 — Jan 2019 [monthly]
Completed NA
-
Jul 2017 — Jun 2018 [monthly]
Completed NA
Phase: PHASE1_PHASE2 → NA
-
Feb 2017 — Jul 2017 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1_PHASE2
First recorded
Apr 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- De Haar Research Task Force
- Transfiguration Clinic
- Ural Federal University
- Ural Institute of Cardiology
- Ural State Medical University
For direct contact, visit the study record on ClinicalTrials.gov .